Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 25043705)

1.

One-week intervention period led to improvements in glycemic control and reduction in DNA damage levels in patients with type 2 diabetes mellitus.

Xavier DJ, Takahashi P, Manoel-Caetano FS, Foss-Freitas MC, Foss MC, Donadi EA, Passos GA, Sakamoto-Hojo ET.

Diabetes Res Clin Pract. 2014 Sep;105(3):356-63. doi: 10.1016/j.diabres.2014.06.004. Epub 2014 Jun 21.

PMID:
25043705
2.

Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice.

Alam MM, Meerza D, Naseem I.

Life Sci. 2014 Jul 25;109(1):8-14. doi: 10.1016/j.lfs.2014.06.005. Epub 2014 Jun 16.

PMID:
24946265
3.

Gene expression profiles displayed by peripheral blood mononuclear cells from patients with type 2 diabetes mellitus focusing on biological processes implicated on the pathogenesis of the disease.

Manoel-Caetano FS, Xavier DJ, Evangelista AF, Takahashi P, Collares CV, Puthier D, Foss-Freitas MC, Foss MC, Donadi EA, Passos GA, Sakamoto-Hojo ET.

Gene. 2012 Dec 15;511(2):151-60. doi: 10.1016/j.gene.2012.09.090. Epub 2012 Oct 2.

PMID:
23036710
4.

DNA damage and plasma antioxidant indices in Bangladeshi type 2 diabetic patients.

Arif M, Islam MR, Waise TM, Hassan F, Mondal SI, Kabir Y.

Diabetes Metab. 2010 Feb;36(1):51-7. doi: 10.1016/j.diabet.2009.05.007. Epub 2009 Dec 29.

5.
6.

Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.

Dave GS, Kalia K.

Cell Mol Biol (Noisy-le-grand). 2007 May 30;53(5):68-78.

PMID:
17543235
7.

DNA and oxidative damages decrease after ingestion of folic acid in patients with type 2 diabetes.

Lazalde-Ramos BP, Zamora-Perez AL, Sosa-Macías M, Guerrero-Velázquez C, Zúñiga-González GM.

Arch Med Res. 2012 Aug;43(6):476-81. doi: 10.1016/j.arcmed.2012.08.013. Epub 2012 Sep 8.

PMID:
22964462
8.

Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control.

Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM.

Mutat Res. 2008 Feb 1;638(1-2):98-102. Epub 2007 Sep 14.

PMID:
17964614
9.

Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.

Wang JS, Lin SD, Lee WJ, Su SL, Lee IT, Tu ST, Tseng YH, Lin SY, Sheu WH.

Clin Ther. 2011 Dec;33(12):1932-42. doi: 10.1016/j.clinthera.2011.10.014. Epub 2011 Nov 10.

PMID:
22078152
10.

Induction and removal of DNA damage in blood leukocytes of patients with type 2 diabetes mellitus undergoing hemodialysis.

Bagatini PB, Palazzo RP, Rodrigues MT, Costa CH, Maluf SW.

Mutat Res. 2008 Dec 8;657(2):111-5. doi: 10.1016/j.mrgentox.2008.08.004. Epub 2008 Aug 19.

PMID:
18773968
11.

Alkaline, Endo III and FPG modified comet assay as biomarkers for the detection of oxidative DNA damage in rats with experimentally induced diabetes.

Kushwaha S, Vikram A, Trivedi PP, Jena GB.

Mutat Res. 2011 Dec 24;726(2):242-50. doi: 10.1016/j.mrgentox.2011.10.004. Epub 2011 Oct 12.

PMID:
22015262
12.

Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes.

Goodarzi MT, Navidi AA, Rezaei M, Babahmadi-Rezaei H.

J Clin Lab Anal. 2010;24(2):72-6. doi: 10.1002/jcla.20328.

PMID:
20333759
13.

Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation.

Sardaş S, Yilmaz M, Oztok U, Cakir N, Karakaya AE.

Mutat Res. 2001 Feb 20;490(2):123-9.

PMID:
11342238
14.

In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM).

Sliwinska A, Blasiak J, Kasznicki J, Drzewoski J.

Chem Biol Interact. 2008 Jun 17;173(3):159-65. doi: 10.1016/j.cbi.2008.03.017. Epub 2008 Apr 8.

PMID:
18485337
15.

DNA damage and repair in type 2 diabetes mellitus.

Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kasznicki J, Zurawska M, Drzewoski J.

Mutat Res. 2004 Oct 4;554(1-2):297-304.

PMID:
15450427
16.

No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients.

Siegelaar SE, Barwari T, Kulik W, Hoekstra JB, DeVries JH.

J Diabetes Sci Technol. 2011 Jan 1;5(1):86-92.

17.

Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes.

Dinçer Y, Akçay T, Alademir Z, Ilkova H.

Mutat Res. 2002 Aug 29;505(1-2):75-81. Erratum in: Mutat Res. 2003 Apr 9;525(1-2):129-30.

PMID:
12175907
18.

Evaluation of oxidative stress markers in pathogenesis of diabetic neuropathy.

Kasznicki J, Kosmalski M, Sliwinska A, Mrowicka M, Stanczyk M, Majsterek I, Drzewoski J.

Mol Biol Rep. 2012 Sep;39(9):8669-78. doi: 10.1007/s11033-012-1722-9. Epub 2012 Jun 21.

19.

Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus.

Pácal L, Varvařovská J, Rušavý Z, Lacigová S, Stětina R, Racek J, Pomahačová R, Tanhäuserová V, Kaňková K.

Arch Physiol Biochem. 2011 Oct;117(4):222-30. doi: 10.3109/13813455.2010.551135. Epub 2011 Feb 22.

PMID:
21338322
20.

Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus.

Choi SW, Benzie IF, Lam CS, Chat SW, Lam J, Yiu CH, Kwan JJ, Tang YH, Yeung GS, Yeung VT, Woo GC, Hannigan BM, Strain JJ.

Diabet Med. 2005 Oct;22(10):1347-53.

PMID:
16176195
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk